|
Efficacy, Safety, LDL Cholesterol Lowering, and 10-Year ASCVD Risk Reduction: Alirocumab and Evolocumab in Addition to Maximal Tolerated LDL Lowering |
|
|
|
Titel: |
Efficacy, Safety, LDL Cholesterol Lowering, and 10-Year ASCVD Risk Reduction: Alirocumab and Evolocumab in Addition to Maximal Tolerated LDL Lowering |
Auteur: |
D'Souza, Kenneth Rothschild, Matan Jetty, Vybhav Anaba, Uzoma Min, Sarah Goldenberg, Naila Wang, Ping Glueck, Charles |
Verschenen in: |
Journal of clinical lipidology |
Paginering: |
Jaargang 11 (2017) nr. 3 pagina's 1 p. |
Jaar: |
2017 |
Inhoud: |
|
Uitgever: |
Published by Elsevier B.V. |
Bronbestand: |
Elektronische Wetenschappelijke Tijdschriften |
|
|
|
|